Compare, Analyse AJANTA PHARMA with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 AJANTA PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-19
ADCOCK INGRAM
Jun-14
AJANTA PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs1,422381-   
Low Rs898275-   
Sales per share (Unadj.) Rs233.5113.2-  
Earnings per share (Unadj.) Rs44.0-28.5-  
Cash flow per share (Unadj.) Rs52.2-23.6-  
Dividends per share (Unadj.) Rs9.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs255.188.9-  
Shares outstanding (eoy) m88.02168.78-   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x5.02.9 171.7%   
Avg P/E ratio x26.4-11.5 -229.7%  
P/CF ratio (eoy) x22.2-13.9 -160.5%  
Price / Book Value ratio x4.53.7 123.3%  
Dividend payout %20.50-   
Avg Mkt Cap Rs m102,08155,292 184.6%   
No. of employees `0006.84.3 158.4%   
Total wages/salary Rs m4,3073,470 124.1%   
Avg. sales/employee Rs Th3,022.64,451.4 67.9%   
Avg. wages/employee Rs Th633.4808.4 78.4%   
Avg. net profit/employee Rs Th569.1-1,121.7 -50.7%   
INCOME DATA
Net Sales Rs m20,55419,110 107.6%  
Other income Rs m211134 157.5%   
Total revenues Rs m20,76519,244 107.9%   
Gross profit Rs m5,664-3,312 -171.0%  
Depreciation Rs m721825 87.4%   
Interest Rs m12518 2.2%   
Profit before tax Rs m5,143-4,520 -113.8%   
Minority Interest Rs m0-13 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,273282 450.7%   
Profit after tax Rs m3,870-4,815 -80.4%  
Gross profit margin %27.6-17.3 -159.0%  
Effective tax rate %24.8-6.2 -396.1%   
Net profit margin %18.8-25.2 -74.7%  
BALANCE SHEET DATA
Current assets Rs m11,81213,997 84.4%   
Current liabilities Rs m3,7767,875 48.0%   
Net working cap to sales %39.132.0 122.1%  
Current ratio x3.11.8 176.0%  
Inventory Days Days77111 69.8%  
Debtors Days Days82124 65.8%  
Net fixed assets Rs m14,3988,159 176.5%   
Share capital Rs m17589 197.7%   
"Free" reserves Rs m22,2770-   
Net worth Rs m22,45214,999 149.7%   
Long term debt Rs m75,271 0.1%   
Total assets Rs m26,96228,335 95.2%  
Interest coverage x444.3-7.7 -5,746.5%   
Debt to equity ratio x00.4 0.1%  
Sales to assets ratio x0.80.7 113.0%   
Return on assets %14.4-15.2 -94.9%  
Return on equity %17.2-32.1 -53.7%  
Return on capital %23.0-19.8 -115.9%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m8,5800-   
CASH FLOW
From Operations Rs m3,7481,631 229.8%  
From Investments Rs m-2,228-501 444.8%  
From Financial Activity Rs m-1,4754,784 -30.8%  
Net Cashflow Rs m455,914 0.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.25 Rs / ZAR

Compare AJANTA PHARMA With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare AJANTA PHARMA With: UNICHEM LAB  STRIDES PHARMA SCIENCE  LUPIN  SUN PHARMA  ALKEM LABORATORIES  



Today's Market

Sensex Falls 471 Points, Nifty Ends Below 14,700; Tata Steel & JSW Steel Top Losers(Closing)

Indian share markets witnessed selling pressure throughout the day today and ended lower.

Related Views On News

AJANTA PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 64.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 64.2% YoY). Sales on the other hand came in at Rs 7 bn (up 15.0% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 46.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 46.3% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

AJANTA PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of AJANTA PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AJANTA PHARMA. Also includes updates on the valuation of AJANTA PHARMA.

More Views on News

Most Popular

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

FREE Event: Discover Your First Stock for a Potential Rs 7 Crore in Long-term Wealth
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

AJANTA PHARMA SHARE PRICE


May 12, 2021 03:36 PM

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AJANTA PHARMA

AJANTA PHARMA 5-YR ANALYSIS

COMPARE AJANTA PHARMA WITH

FEATURED VIDEOS

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

More Featured Videos

MARKET STATS